Want to see JP:8095 full AI Analyst Report?
Astena Holdings Co.,Ltd. (8095) Stock Price & Analysis
8095 Stock Chart & Stats
- Day’s Range
- JPY 549.00 - JPY 562.00
- 52-Week Range
- JPY 456.00 - JPY 562.00
- Previous Close
- JPY 552.00
- Volume
- 111.30K
- Average Volume (3M)
- 173.63K
- Market Cap
- JPY 22.60B
- Enterprise Value
- JPY 35.83B
- Total Cash (Recent Filing)
- JPY 10.19B
- Total Debt (Recent Filing)
- JPY 22.65B
- Price to Earnings (P/E)
- 8.8
- Beta
- 0.62
- Next Earnings
- Jan 08, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- Nov 27, 2026
- Dividend Yield
- 3.22%
Bulls Say, Bears Say
Bulls Say
Improving Gross Margins
Sustained expansion of gross margin reflects structural improvement in cost base or product mix. Higher gross margins enhance operating leverage, improve resilience to input-cost shocks, and create durable capacity to fund R&D, dividends, or debt reduction over coming quarters.
Consistent Revenue Growth
Positive top-line trend, including a rebound, indicates stable demand and market positioning. Persistent revenue growth supports scale economies, steadier margins, and the ability to invest in pipeline and commercial expansion, making performance less dependent on one-off events.
Return To Profitability
Re-establishing positive net income after loss demonstrates operational fixes and improves internal funding capacity. A measurable return to profit supports sustainable cash flows and credibility with lenders and partners, helping strategic execution over the next several quarters.
Bears Say
Earnings Volatility
Pronounced swings in net income undermine predictability for capital allocation, dividend coverage, and investment planning. Persistent volatility raises the likelihood that earnings can revert, constraining strategic decisions and increasing the premium required by creditors and partners.
Weak Cash Generation
Unreliable free cash flow and thin conversion of earnings into cash limit the firm’s ability to self-fund capex, R&D, and dividends, and increase reliance on external financing. This structural cash risk reduces flexibility over the medium term and heightens refinancing vulnerability.
Increased Leverage In 2025
Higher debt levels in 2025 weaken balance-sheet optionality and raise interest burden. Coupled with earnings and cash volatility, elevated leverage amplifies solvency and refinancing risk, limiting capacity to absorb shocks or pursue growth without additional external funding.
Astena Holdings Co.,Ltd. News
Astena Holdings Confirms Special Account Settlement and Maintains Stable Dividend Policy
An update from Astena Holdings Co.,Ltd. ( ($JP:8095) ) is now available. Astena Holdings Co., Ltd., a TSE Prime Market-listed diversified group, manages shareholder returns under a stable, performance-linked dividend
Astena Holdings to Book ¥464 Million Dividend From Subsidiary Without Affecting Group Earnings
Astena Holdings Co.,Ltd. ( ($JP:8095) ) just unveiled an announcement. Astena Holdings has announced it will receive a 464 million yen dividend from its consolidated subsidiary Iwaki Seiyaku Co., Ltd.,
8095 FAQ
What was Astena Holdings Co.,Ltd.’s price range in the past 12 months?
What is Astena Holdings Co.,Ltd.’s market cap?
When is Astena Holdings Co.,Ltd.’s upcoming earnings report date?
How were Astena Holdings Co.,Ltd.’s earnings last quarter?
Is Astena Holdings Co.,Ltd. overvalued?
Does Astena Holdings Co.,Ltd. pay dividends?
What is Astena Holdings Co.,Ltd.’s EPS estimate?
How many shares outstanding does Astena Holdings Co.,Ltd. have?
What happened to Astena Holdings Co.,Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Astena Holdings Co.,Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Astena Holdings Co.,Ltd.
Astena Holdings Co., Ltd., a Japanese company founded in 1914 and based in Chuo, is engaged in the development and distribution of a wide array of healthcare and chemical products. Its Fine Chemical division specializes in manufacturing and selling active pharmaceutical ingredients (APIs) and vital medical supplies used in treatments for fever reduction, pain relief, inflammation management, and blood vessel constriction. The Medical division focuses on biotechnology-related activities, providing support services for drug development and distributing essential medical equipment. The Health & Beauty Care, and Food segment is responsible for marketing non-prescription medications, raw materials for food and functional food products, and cosmetic ingredients. This division also manages direct-to-consumer sales through online and mail-order platforms, alongside offering contract manufacturing services for cosmetic items. Additionally, Astena Holdings' Industrial Chemicals division produces and supplies specialized chemicals for surface treatment and other industrial applications, serving sectors such as printed circuit boards, electronic devices, general plating processes, and semiconductors. The company, initially known as Iwaki & Co., Ltd., officially adopted the name Astena Holdings Co., Ltd. in June 2021.
- Sector
- Industrials
- Industry
- Medical - Pharmaceuticals
- CEO
- Satoshi Setoguchi
- Employees
- 1,543
- Website
- www.astena-hd.com
- Address
- 4-8-2 Nihonbashihoncho, Tokyo, TY, 103-8403, JP
Astena Holdings Co.,Ltd. (8095) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 15 | 2 | 5 |
| Technical Analysis | 3 | 2 | 5 |
| Moving Averages | 12 | 0 | 0 |






